Regulations.gov document
Attachment 6 - "Excerpt From Canadian Supplemental New Drug Submission (December 1996…
Supporting & Related Material · FDA-2003-P-0351 · posted Aug 13, 2008
Key facts
| Document ID | FDA-2003-P-0351-0016 |
|---|---|
| Title | Attachment 6 - "Excerpt From Canadian Supplemental New Drug Submission (December 1996 Section 3.2.2.2.2)" [Wyeth Pharmaceuticals (Wyeth) - Comment] |
| Document type | Supporting & Related Material |
| Subtype | C-Comment (Supporting and Related Material) |
| Agency | FDA |
| Docket | FDA-2003-P-0351 |
| Posted | Aug 13, 2008 |
| Effective date | Aug 28, 2003 |
At a glance
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: